These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3925627)

  • 1. The Omenn's syndrome: histological, immunohistochemical and ultrastructural evidence for a partial T cell deficiency evolving in an abnormal proliferation of T lymphocytes and S-100 +/T-6 + Langerhans-like cells.
    Ruco LP; Stoppacciaro A; Pezzella F; Mirolo M; Uccini S; Barsotti P; Cassano AM; Boner AL; Businco L; Di Fazio A
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(1):69-82. PubMed ID: 3925627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lymph node pathology of Omenn's syndrome.
    Martin JV; Willoughby PB; Giusti V; Price G; Cerezo L
    Am J Surg Pathol; 1995 Sep; 19(9):1082-7. PubMed ID: 7661282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunological findings in four infants with Omenn's syndrome: a form of severe combined immunodeficiency with phenotypically normal T cells, elevated IgE, and eosinophilia.
    Businco L; Di Fazio A; Ziruolo MG; Boner AL; Valletta EA; Ruco LP; Vitolo D; Ensoli B; Paganelli R
    Clin Immunol Immunopathol; 1987 Aug; 44(2):123-33. PubMed ID: 3111764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reticuloendotheliosis with eosinophilia (Omenn's syndrome). Findings in fine needle aspirate of a lymph node.
    Baybick JH
    Acta Cytol; 1987; 31(1):20-4. PubMed ID: 3468712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omenn's syndrome and related combined immunodeficiency syndromes: diagnostic considerations in infants with persistent erythroderma and failure to thrive.
    Pupo RA; Tyring SK; Raimer SS; Wirt DP; Brooks EG; Goldblum RM
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):442-6. PubMed ID: 1832695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune status in two brothers with Omenn's syndrome: no discernible chimerism on FACS analysis using a monoclonal antibody specific for a maternally restricted HLA antigen.
    Tachinami T; Koizumi S; Yachie A; Yamagami M; Yokoi T; Ohno I; Taniguchi N; Takada I; Kawashima A; Okada Y
    Am J Pediatr Hematol Oncol; 1990; 12(3):343-50. PubMed ID: 2240484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Omenn syndrome].
    Glastre C; Rigal D
    Pediatrie; 1990; 45(5):301-5. PubMed ID: 2165240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omenn's syndrome--pathologic arguments in favor of a graft versus host pathogenesis: a report of nine cases.
    Jouan H; Le Deist F; Nezelof C
    Hum Pathol; 1987 Nov; 18(11):1101-8. PubMed ID: 3679186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome).
    de Saint-Basile G; Le Deist F; de Villartay JP; Cerf-Bensussan N; Journet O; Brousse N; Griscelli C; Fischer A
    J Clin Invest; 1991 Apr; 87(4):1352-9. PubMed ID: 2010548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalances in subsets of T lymphocytes in an inbred pedigree with Omenn's syndrome.
    Karol RA; Eng J; Cooper JB; Dennison DK; Sawyer MK; Lawrence EC; Marcus DM; Shearer WT
    Clin Immunol Immunopathol; 1983 Jun; 27(3):412-27. PubMed ID: 6223759
    [No Abstract]   [Full Text] [Related]  

  • 11. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).
    Purtilo DT; Cassel CK; Yang JP; Harper R
    Lancet; 1975 Apr; 1(7913):935-40. PubMed ID: 48119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity for S-100 protein in dendritic and in lymphocyte-like cells in human lymphoid tissues.
    Uccini S; Vitolo D; Stoppacciaro A; Paliotta D; Cassano AM; Barsotti P; Ruco LP; Baroni CD
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(2):129-41. PubMed ID: 2878529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.
    Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G
    Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of CD3+CD4-CD8- T cell population expressing high levels of IL-5 in Omenn's syndrome.
    Melamed I; Cohen A; Roifman CM
    Clin Exp Immunol; 1994 Jan; 95(1):14-21. PubMed ID: 8287598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node modification in patients with the acquired immunodeficiency syndrome (AIDS) or with AIDS related complex (ARC). A histological, immuno-histopathological and ultrastructural study of 45 cases.
    Diebold J; Marche C; Audouin J; Aubert JP; Le Tourneau A; Bouton C; Reynes M; Wizniak J; Capron F; Tricottet V
    Pathol Res Pract; 1985 Dec; 180(6):590-611. PubMed ID: 3913948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omenn's syndrome: lessons from a red baby.
    Katugampola RP; Morgan G; Khetan R; Williams N; Blackford S
    Clin Exp Dermatol; 2008 Jul; 33(4):425-8. PubMed ID: 18498405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic expression of T lymphocytes in thymus and peripheral lymphoid tissues.
    Hsu SM; Jaffe ES
    Am J Pathol; 1985 Oct; 121(1):69-78. PubMed ID: 3931482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary membrane T cell immunodeficiencies.
    Le Deist F; de Saint Basile G; Mazerolles F; Thoenes G; De Villartay JP; Cerf-Bensussan N; Lisowska-Grospierre B; Griscelli C; Fischer A
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S56-60. PubMed ID: 1834382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypical and functional characterization of double-negative (CD4-CD8-) alpha beta T-cell receptor positive cells from an immunodeficient patient.
    Illum N; Ralfkiaer E; Pallesen G; Geisler C
    Scand J Immunol; 1991 Nov; 34(5):635-45. PubMed ID: 1835126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cell death of activated lymphocytes in Omenn's syndrome.
    Brugnoni D; Airò P; Facchetti F; Blanzuoli L; Ugazio AG; Cattaneo R; Notarangelo LD
    Eur J Immunol; 1997 Nov; 27(11):2765-73. PubMed ID: 9394797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.